Description: Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases. The company's product includes ColdZyme mouth spray, which prevents common cold and reduces the duration of illness. It also provides enzyme formulations. The company sells mouth spray under the ViruProtect brand in Denmark; STADAProtect brand in Germany; Psysiomer Stop Virus brand in France; and Zerinol Virus Defense brand in Italy. Enzymatica AB was incorporated in 2007 and is headquartered in Lund, Sweden.
Home Page: www.enzymatica.se
Ideon Science Park
Lund,
223 70
Sweden
Phone:
46 4 62 86 31 00
Officers
| Name | Title |
|---|---|
| Mr. Claus Egstrand | Chief Exec. Officer |
| Ms. Therese Filmersson | CFO & Deputy CEO |
| Mr. Stefan Olsson | Communication Mang. |
| Mr. Ulf Blom | Exec. VP of Marketing & Operations |
Exchange: ST
Country: SE : Sweden
Currency: Swedish krone (kr)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 66.6667 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 47.2544 |
| Price-to-Sales TTM: | 14.2876 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 23 |